BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23786153)

  • 1. Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma.
    Kaseda K; Ishii G; Aokage K; Takahashi A; Kuwata T; Hishida T; Yoshida J; Kohno M; Nagai K; Ochiai A
    Cancer Sci; 2013 Sep; 104(9):1262-9. PubMed ID: 23786153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.
    Sekihara K; Hishida T; Ikemura S; Saruwatari K; Morise M; Kuwata T; Fujii S; Kojima M; Ochiai A; Funai K; Aokage K; Yoshida J; Tsuboi M; Ishii G
    J Cancer Res Clin Oncol; 2016 May; 142(5):905-12. PubMed ID: 26696594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma.
    Hisakane K; Saruwatari K; Fujii S; Kirita K; Umemura S; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Kuwata T; Ochiai A; Gemma A; Tsuboi M; Goto K; Ishii G
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):593-600. PubMed ID: 26521256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
    Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
    PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
    Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
    J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.
    Matsuwaki R; Ishii G; Zenke Y; Neri S; Aokage K; Hishida T; Yoshida J; Fujii S; Kondo H; Goya T; Nagai K; Ochiai A
    Cancer Sci; 2014 Jul; 105(7):905-11. PubMed ID: 24814677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.
    Qiu X; Chen D; Liu Y; Duan S; Zhang F; Zhang Y; Li F; Chen C; Chen Y
    Thorac Cancer; 2019 Feb; 10(2):256-267. PubMed ID: 30605235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
    Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.
    Zhao J; Zhao Y; Xuan Y; Jiao W; Qiu T; Wang Z; Luo Y
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e125-9. PubMed ID: 26728670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
    Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
    Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
    Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
    Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer.
    Yang X; Liu Y; Mani H; Olson J; Clawson G; Caruso C; Bruggeman R; Varlotto JM; Zander DS; Rassaei N
    Pathol Oncol Res; 2017 Jan; 23(1):73-77. PubMed ID: 27411924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
    Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
    J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
    Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
    Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis.
    Matsumura Y; Ishii G; Aokage K; Kuwata T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
    Cancer Sci; 2012 Jul; 103(7):1342-7. PubMed ID: 22429811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.
    Ibrahim R; Matsubara D; Osman W; Morikawa T; Goto A; Morita S; Ishikawa S; Aburatani H; Takai D; Nakajima J; Fukayama M; Niki T; Murakami Y
    Hum Pathol; 2014 Jul; 45(7):1397-405. PubMed ID: 24775604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
    Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
    PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.